Phytochemicals in Cancer Chemoprevention: Preclinical and Clinical Studies
Cancer Control · 2024
DOI: 10.1177/10732748241302902 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Control, 2024. Verfasst von Nitish Lekhak und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Kathmandu University, Dhulikhel, Nepal. Hauptthemen laut MEDLINE: Phytochemicals, Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 323 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Phytochemicals, chemicals from plants, have garnered huge attention for their potential ability to prevent cancer. In vivo and preclinical models show that they do so often by affecting the hallmarks of cancer. Phytochemicals affect key pathways involved in the survival, genome maintenance, proliferation, senescence, and transendothelial migration of cancer cells. Some phytochemicals, namely antioxidants, can scavenge and quench reactive oxygen species (ROS) to prevent lipid peroxidation and DNA damage. They also trigger apoptosis by stopping the cell cycle at checkpoints to initiate the DNA damage response. Numerous in vitro and in vivo studies suggest that phytochemicals hinder cancer onset and progression by modifying major cell signaling pathways such as JAK/STAT, PI3K/Akt, Wnt, NF-kB, TGF-β, and MAPK. It is a well-known fact that the occurrence of cancer is in itself a very intricate process involving multiple mechanisms concurrently. Cancer prevention using phytochemicals is also an equally complex process that requires investigation and understanding of a myriad of processes going on in the cells and tissues. While many in vitro and preclinical studies have established that phytochemicals may be potential chemopreventive agents of cancer, their role in clinical randomized control trials needs to be established. This paper aims to shed light on the dynamics of chemoprevention using phytochemicals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Kathmandu University, Dhulikhel, Nepal.
ORCID-Profile: Nitish Lekhak, Hitesh Kumar Bhattarai
Zitieren
APA
Lekhak, N., & Bhattarai, H. K. (2024). Phytochemicals in Cancer Chemoprevention: Preclinical and Clinical Studies. Cancer Control. https://doi.org/10.1177/10732748241302902
Vancouver
Lekhak N, Bhattarai HK. Phytochemicals in Cancer Chemoprevention: Preclinical and Clinical Studies. Cancer Control. 2024. doi:10.1177/10732748241302902
BibTeX
@article{Lekhak2024,
author = {Lekhak, Nitish and Bhattarai, Hitesh Kumar},
title = {Phytochemicals in Cancer Chemoprevention: Preclinical and Clinical Studies},
journal = {Cancer Control},
year = {2024},
doi = {10.1177/10732748241302902}
}
EUVIMED